ロード中...
Semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5
Glycoconjugate vaccines based on isolated capsular polysaccharide (CPS) save millions of lives annually by preventing invasive pneumococcal disease caused by Streptococcus pneumoniae. Some components of the S. pneumoniae glycoconjugate vaccine Prevnar13 that contains CPS antigens from 13 serotypes u...
保存先:
| 出版年: | Proc Natl Acad Sci U S A |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
National Academy of Sciences
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5651752/ https://ncbi.nlm.nih.gov/pubmed/28973947 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1706875114 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|